DEVELOPING A PREDICTIVE MODEL FOR PROGRESSION TO DIALYSIS IN STAGE 4 SEVERE CHRONIC KIDNEY DISEASE PATIENTS

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/7ca183f8f2b4ae5173b7dfd4fc58c2a7.pdf
DEVELOPING A PREDICTIVE MODEL FOR PROGRESSION TO DIALYSIS IN STAGE 4 SEVERE CHRONIC KIDNEY DISEASE PATIENTS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
SHU-CHEN
LAI
SHU-CHEN LAI Y08143@ms1.ylh.gov.tw NATIONAL TAIWAN UNIVERSITY HOSPITAL YUNLIN BRANCH DEPARTMENT OF EDUCATION AND RESEARCH YUNLIN Taiwan *
WEN-YI LI Y00905@ms1.ylh.gov.tw NATIONAL TAIWAN UNIVERSITY HOSPITAL YUNLIN BRANCH DEPARTMENT OF NEPHROLOGY YUNLIN Taiwan -
YU-HSIU LIN yuhsiu@ccu.edu.tw DEPARTMENT OF INFORMATION MANAGEMENT NATIONAL CHUNG CHENG UNIVERSITY CHIAYI Taiwan -
 
 
 
 
 
 
 
 
 
 
 
 

The global burden of chronic kidney disease (CKD) continues to escalate, with both incidence and prevalence showing sustained upward trends across populations. As such, early detection, prevention, and strategies to slow disease progression have emerged as critical priorities for public health systems worldwide. As CKD advances to end-stage renal disease (ESRD), characterized by a glomerular filtration rate (GFR) of less than 15 ml/min/1.73m², patients typically require renal replacement therapies, such as dialysis or kidney transplantation. These interventions not only place substantial strain on healthcare resources but also significantly affect patients’ quality of life and increase the burden on caregiving and support systems.

This study focuses on individuals diagnosed with stage 4 CKD (15≤GFR<30 ml/min/1.73m²), who received care at a northern tertiary medical center and a central regional teaching hospital in Taiwan. It aims to develop machine learning-based predictive models to identify clinical and demographic risk factors and to assist clinical decision-making and individualized patient management.

A total of 5,508 patients with CKD4 were retrospectively identified from integrated healthcare databases covering the period from January 1, 2016, to December 31, 2023. Predictors: age, gender, BMI, occupation, betel quid chewing, diabetes mellitus, hypertension, cardiovascular disease, heart failure, anemia, proteinuria, total cholesterol, low-density lipoprotein cholesterol, triglycerides, hypertriglyceridemia, hemoglobin, uric acid, serum sodium, serum phosphorus, serum calcium, and serum potassium. The dataset was randomly partitioned into a training (70%) and a testing (30%) subsets using SAS Enterprise Miner (EM) 15.2 (SAS Institute Inc., Cary, NC, USA). Predictive models were developed using five machine learning algorithms—decision tree (DT), random forest (RF), artificial neural network (ANN), logistic regression (LR), and support vector machine (SVM)—within the SAS EM. Model performance was assessed through repeated 10-fold cross-validation and confusion matrix-based metrics. To enhance model interpretability, feature importance was evaluated using SHapley Additive exPlanations (SHAP) values, implemented in Python 3.10 (Python Software Foundation), to identify the most influential predictors of dialysis initiation.

A three-year follow-up was conducted from the time patients were enrolled, at which point their eGFR ranged between 15 and 30 mL/min/1.73 m², 3,323 patients (60.33%) progressed to dialysis, while 2,185 patients (39.67%) remained stable or improved. Among the machine learning models evaluated, the ANN demonstrated the highest predictive performance (AUC=0.757, F1-score=0.762) when trained on the full set of features. SHAP analysis further revealed serum phosphate level, age, heart failure, proteinuria, and sex as the most influential predictors of progression.

Table 1. Average performance scores of the predictive model: Full Model

 

Algorithms

Accuracy

Precision

Sensitivity

Specificity

F1-Score

AUC

train set

DT

0.674

0.720

0.573

0.775

0.637

0.714

RF

0.773

0.793

0.739

0.807

0.850

0.773

ANN

0.696

0.710

0.663

0.723

0.686

0.696

LR

0.686

0.707

0.636

0.736

0.669

0.686

SVM

0.687

0.724

0.605

0.769

0.659

0.687

test set

DT

0.668

0.712

0.568

0.769

0.630

0.698

RF

0.693

0.711

0.653

0.735

0.790

0.694

ANN

0.757

0.775

0.751

0.763

0.762

0.757

LR

0.682

0.703

0.633

0.732

0.666

0.683

SVM

0.681

0.716

0.599

0.763

0.652

0.681

SHAP

Figure 1. SHAP value ranking of each variable in predicting CKD stage 4 progression to dialysis

Figure 2. SHAP bee swarm plot of each variable’s impact on the model

This study highlights serum phosphate level, age, heart failure, proteinuria, and sex as the most influential predictors of progression from CKD4 to dialysis. The machine learning-based predictive models developed herein offer a robust, data-driven framework for early identification of high-risk patients, thereby facilitating personalized treatment planning and more efficient allocation of healthcare resource in nephrology practice. These findings underscore the potential of integrative analytics to augment clinical decision-making and support proactive, evidence-informed intervention strategies aimed at delaying dialysis initiation and improving patient outcomes.

Kewords